Headlines:
- Blair William & Co. IL Reduces Rocket Lab USA Holdings by 25.4%
- Other Major Investors Adjust Positions in Rocket Lab USA
- Recent Insider Transactions at Rocket Lab USA
Blair William & Co. IL reduced its holdings in Rocket Lab USA, Inc. (NASDAQ) by 25.4% during the first quarter, as disclosed in their recent SEC filing. The fund now owns 258,773 shares of Rocket Lab, having sold 88,145 shares during the period. As of the end of the quarter, Blair William & Co. IL’s stake in Rocket Lab was valued at approximately $1,064,000, representing about 0.05% of the company.
In addition to this change, other significant investors have also adjusted their positions. Spire Wealth Management increased its holdings in Rocket Lab (NASDAQ:RKLB)by 257.1% during the first quarter, acquiring 7,200 additional shares to bring their total to 10,000 shares worth $41,000. Brown Advisory Inc. made a new investment in Rocket Lab USA during the fourth quarter, valued at approximately $61,000. Psagot Value Holdings Ltd. Israel significantly expanded its stake by 1,044.9%, owning 14,037 shares valued at $81,000 after purchasing 12,811 additional shares. Cerity Partners LLC raised its holdings by 14.5%, now owning 17,630 shares worth $97,000 after buying 2,230 extra shares. Fagan Associates Inc. also acquired a new stake valued at about $103,000 in the fourth quarter. Overall, hedge funds and institutional investors hold 71.78% of Rocket Lab’s stock.
In other developments, Rocket Lab CFO Adam C. Spice sold 63,529 shares on May 24th, at an average price of $4.22, totaling $268,092.38. After the sale, he retains 1,383,677 shares valued at approximately $5,839,116.94. Additionally, General Counsel Arjun Kampani sold 29,026 shares on the same day, with a transaction value of $122,489.72, leaving him with 666,121 shares valued at $2,811,030.62. Insider ownership stands at 13.70% of the company’s stock.
As for the company’s performance, Rocket Lab USA shares opened at $5.34. The company has a current ratio of 3.12, a quick ratio of 2.69, and a debt-to-equity ratio of 0.86. The 50-day moving average is $4.70, and the 200-day moving average is $4.46, with a twelve-month low of $3.47 and a high of $7.79. Rocket Lab USA recently reported its quarterly earnings on May 6th, showing a loss of $0.09 per share, which was better than the anticipated loss of $0.11. The company reported revenue of $92.80 million for the quarter, slightly below analyst estimates. The firm has a negative net margin of 64.15% and a negative return on equity of 32.50%. Revenue increased by 69.0% year-over-year. Analysts forecast that Rocket Lab USA will post an EPS of -$0.41 for the current year.